TG THERAPEUTICS, INC. (TGTX)
Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014Q1-CY2014
Balance Sheet Date2025-Dec-312025-Sep-302025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-312023-Sep-302023-Jun-302023-Mar-312022-Dec-312022-Sep-302022-Jun-302022-Mar-312021-Dec-312021-Sep-302021-Jun-302021-Mar-312020-Dec-312020-Sep-302020-Jun-302020-Mar-312019-Dec-312019-Sep-302019-Jun-302019-Mar-312018-Dec-312018-Sep-302018-Jun-302018-Mar-312017-Dec-312017-Sep-302017-Jun-302017-Mar-312016-Dec-312016-Sep-302016-Jun-302016-Mar-312015-Dec-312015-Sep-302015-Jun-302015-Mar-312014-Dec-312014-Sep-302014-Jun-302014-Mar-31
Fiscal PeriodQ4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q4-FY2023Q3-FY2023Q2-FY2023Q1-FY2023Q4-FY2022Q3-FY2022Q2-FY2022Q1-FY2022Q4-FY2021Q3-FY2021Q2-FY2021Q1-FY2021Q4-FY2020Q3-FY2020Q2-FY2020Q1-FY2020Q4-FY2019Q3-FY2019Q2-FY2019Q1-FY2019Q4-FY2018Q3-FY2018Q2-FY2018Q1-FY2018Q4-FY2017Q3-FY2017Q2-FY2017Q1-FY2017Q4-FY2016Q3-FY2016Q2-FY2016Q1-FY2016Q4-FY2015Q3-FY2015Q2-FY2015Q1-FY2015Q4-FY2014Q3-FY2014Q2-FY2014Q1-FY2014
Operating Cash Flow19,660,000$(23,153,000$)7,436,000$(28,715,000$)(25,641,000$)(12,205,000$)5,536,000$(8,207,000$)(13,210,000$)83,704,000$(42,005,000$)(59,902,000$)(23,870,000$)(34,495,000$)(49,116,000$)(68,689,000$)(86,909,000$)(67,201,000$)(60,169,000$)(81,355,000$)(52,026,000$)(56,532,000$)(43,834,000$)(62,115,000$)(30,393,000$)(33,202,000$)(35,860,000$)(33,351,000$)
Investing Cash Flow(15,638,000$)46,363,000$(3,992,000$)(12,934,000$)15,788,000$(9,334,000$)1,765,000$(9,255,000$)(44,755,000$)(30,229,000$)30,501,000$(6,168,000$)16,269,000$(2,990,000$)10,379,000$(43,671,000$)3,288,000$(631,000$)(2,475,000$)(514,000$)(52,076,000$)14,911,000$11,205,000$1,450,000$4,000$(44,000$)457,000$(1,135,000$)
Purchases of Property and Equipment67,000$80,000$42,000$25,000$21,000$3,000$4,000$0$7,000$80,000$79,000$175,000$67,000$155,000$89,000$45,000$68,000$34,000$65,000$18,000$14,000$6,000$26,000$34,000$24,000$0$0$2,000$0$20,985$12,959$27,795$282,261$(16,977$)38,914$13,397$6,883$14,072$1,333$0$3,165$
Financing Cash Flow1,058,000$(78,242,000$)(6,443,000$)(6,102,000$)(6,072,000$)134,454,000$135,000$10,000$(1,000$)421,000$47,047,000$25,238,000$49,000$275,000$135,000$(850,000$)55,997,000$(7,361,000$)(7,162,000$)(55,000$)403,389,000$35,265,000$241,092,000$81,000$98,354,000$20,695,000$28,284,000$56,880,000$
End Cash Position79,148,000$74,081,000$129,126,000$132,139,000$179,894,000$195,822,000$82,910,000$75,477,000$92,933,000$150,902,000$97,009,000$61,469,000$102,304,000$109,860,000$147,073,000$185,676,000$298,887,000$326,512,000$401,707,000$471,514,000$553,439,000$254,154,000$260,512,000$52,051,000$112,637,000$44,675,000$57,228,000$64,349,000$41,958,000$70,718,000$105,672,000$82,896,000$56,718,000$91,842,000$77,602,000$95,638,000$25,031,000$29,156,521$28,577,832$36,478,420$55,061,329$65,461,940$60,300,086$86,004,445$55,713,784$53,225,799$37,077,977$49,596,327$
Exchange Rate Effect
Dividends Paid
Unlevered Free Cash Flow19,593,000$(23,233,000$)7,394,000$(28,740,000$)(25,662,000$)(12,205,000$)5,536,000$(8,207,000$)(13,210,000$)83,704,000$(42,005,000$)(59,902,000$)(23,873,000$)(34,499,000$)(49,116,000$)(68,696,000$)(86,989,000$)(67,280,000$)(60,344,000$)(81,422,000$)(52,181,000$)(56,621,000$)(43,879,000$)(62,183,000$)(30,427,000$)(33,267,000$)(35,878,000$)(33,365,000$)